市场调查报告书
商品编码
1163393
生医光电(Biophotonics)的全球市场-市场规模,市场区隔,展望,收益预测:各技术,各终端用户,各用途,各地区(2022年~2028年)Global Biophotonics Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 by Technology, End User, Application, and Regions |
全球生医光电(Biophotonics)的市场规模在2017年估算为约300亿美元,到2022年达到约500亿美元,到2028年前将达到约1,000亿美元,在预测期间内预计将以12%的年复合成长率成长。航空航天和通信领域光学技术的进步、私人和政府对研发的资助预计将推动市场增长。然而,生物光子学技术的复杂性、基于生物光子学的设备的高成本可能会限制市场增长。
本报告提供全球生医光电(Biophotonics)市场相关调查分析,提供主要的趋势,竞争情形,市场分析等系统性资讯。
免责声明
Market Overview
Biophotonics is the study of optical processes in biological systems, both those that occur naturally and in bioengineered materials. A particularly important aspect of this field is imaging and sensing cells and tissue. This includes injecting fluorescent markers into a biological system to track cell dynamics and drug delivery. Furthermore, biophotonics has many applications in the fields of medicine, genetics, biology, agriculture and environmental science.
According to Ken Research Analysis, the Global Biophotonics Market was valued at ~US$ 30 billion in 2017. Furthermore, owing to the development in biosensors and increased use of biophotonics in the nonmedical sector, it is estimated to be ~US$ 50 billion in 2022 and is expected to reach a market size of ~US$ 100 billion by 2028 growing with a CAGR of ~12% during 2022 to 2028.
The recent surge of nanotechnology, combined with increasing demand for home-based Point-of-Care (POC) devices, is expected to drive market growth in the coming years.
Advances in optical technologies in the aerospace and telecommunications sectors, combined with the availability of private and government funds for R&D, are also expected to boost the market growth.
The complexity of biophotonics technology, combined with the high cost of biophotonics-based instruments, may stifle market growth.
The ongoing COVID-19 pandemic has hampered biophotonics market growth by disrupting hospital care for non-COVID-19 patients in hospitals and other end-user facilities across countries.
Scope of the Report
The Global Biophotonics Market is segmented by technology, end-user, and application. In addition, the report also covers market size and forecasts for the four major regions in the stem cell banking Market. The revenue used to size and forecast the market for each segment is US$ billion.
By Technology
In-Vivo
In-Vitro
By End User
Tests and Components
Medical Therapeutics
Medical Diagnostics
Non-Medical Application
By Application
Surface Imaging
Inside Imaging
See-through Imaging
Microscopy
Bio Sensors
Analytical Sensing
Spectromolecular
Others
By Region
North America (USA, Canada, and Mexico)
Europe (France, Italy, Germany, Spain, UK, and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, and Rest of Asia Pacific)
LAMEA (Latin America, Middle East, and Africa)
Key Players
Affymetrix Inc.
Andor Technology
BD (Becton, Dickinson and Company)
Carl Zeiss AG
Olympus Corporation
Hamamatsu Photonics K.K
Zecotek Photonic Inc.
Idex Corporation
IPG Photonics
Oxford Instruments Plc
Key Trends by Market Segment
By Technology: The In-Vitro segment held the largest market share of the global biophotonics market in 2021.
In-Vitro basically used studying cells in culture or methods of testing the antibiotic sensitivity of bacteria.
Furthermore, in-vitro optical imaging is being conducted in a variety of medical applications, such as optical breast cancer imaging, functional brain imaging, endoscopy, exercise medicine, and monitoring the photodynamic therapy and progress of neoadjuvant chemotherapy.
By End-User: The Medical Diagnostics segment held the largest market share of the global biophotonics market in 2021.
Diagnostic biophotonics is used to detect diseases in their initial stages before actual medical symptoms occur in patients.
Furthermore, they provide several advantages of sensing and imaging at the molecular level and also collect multidimensional data for evaluation.
By Application: The Analytical Sensing segment held the largest market share of the global biophotonics market in 2021.
It is a two-part analytic device that consists of two major components: a (bio) chemical microzone (recognition element) that comes into contact with the sample and is closely associated (connected or integrated) with an optical, electric, thermal, mass, or acoustic transducer for converting the recognition pattern into a (usually electric or optical) primary signal that can be amplified and measured by a detector (instrument).
Furthermore, they typically respond to the presence and/or concentration (activity) of an analyte species.
By Geography: North America accounts for the largest share among all regions within the Global Biophotonics market.
Rapid advancements in the development and adoption of digital health technologies (DHT) across North America, notably in the United States, are one of the major contributing factors to the growth of biophotonics.
Increasing regional government initiatives and strategies, favorable healthcare infrastructure, increased investment in R&D activities to develop the industry, and regulatory science activities across the healthcare industry are also propelling the biophotonics market growth in North America.
Competitive Landscape
The Global Biophotonics market is highly competitive with ~200 players which include globally diversified players, regional players as well as a large number of country-niche players each with their niche in pharma and diagnostics solutions, and technologies, such as vitro analyses of DNA variation, RNA expression, metabolite quantification, vivo measurements of biological processes, and others, for end-user industries. The biophotonics market's growth is heavily reliant on technological advancement and R&D investment. Nowadays, numerous pharmaceutical companies are investing in R&D or drug research, and governments are also making significant investments in cancer research.
Country-Niche players comprise about ~50% of the competitors, while regional players hold a share of ~30%. Some of the major players in the market include Affymetrix Inc., Andor Technology, BD (Becton, Dickinson and Company), Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Zecotek Photonic Inc., Idex Corporation, IPG Photonics, Oxford Instruments Plc., and among others.
Conclusion
The Global Biophotonics Market is forecasted to continue an rapid growth that is witnessed since 2019, during the forecast period also, primarily driven by the emergence of applied science, important technological advancements over a few years, and their adoption in the medical sector. Though the market is highly competitive with over ~200 participants, few country-niche players control the dominant share.
Note: This is an On-Demand/Planned report, so the figures quoted here for a market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and the report delivered within a maximum of 2 working weeks.
Key Topics Covered in the Report
Snapshot of Global Biophotonics Market
Industry Value Chain and Ecosystem Analysis
Market size and Segmentation of Global Biophotonics Market
Historic Growth of Overall Global Biophotonics Market and Segments
Competition Scenario of the Market and Key Developments of Competitors
Porter's 5 Forces Analysis of Global Biophotonics Industry
Overview, Product Offerings, and SWOT Analysis of Key Competitors
COVID-19 Impact on the Overall Global Biophotonics Market
Future Market Forecast and Growth Rates of the Total Global Biophotonics Market and by Segments
Market Size of Application / End User Segments with Historical CAGR and Future Forecasts
Analysis of Global Biophotonics Market
Major Production/Supply and Consumption/Demand Hubs within Each Region
Major Country-wise Historic and Future Market Growth Rates of the Total Market and Segments
Overview of Notable Emerging Competitor Companies within Each Region
Major Companies Mentioned in the Report
Affymetrix Inc.
Andor Technology
BD (Becton, Dickinson and Company)
Carl Zeiss AG
Olympus Corporation
Hamamatsu Photonics K.K
Zecotek Photonic Inc.
Idex Corporation
IPG Photonics
Oxford Instruments Plc
Notable Emerging Companies Mentioned in the Report
Lumicks
Creoptix
ThnikCyte
PhotoPharmics
Impedimed
Norlase
Vivosight
Speclipse
Key Target Audience - Organizations and Entities Who Can Benefit by Subscribing This Report
Biotechnology - Therapeutics and Diagnostics Companies
Pharmaceutical Companies
Manufacturers of Diagnostic Kits and Instruments
International Agency for Research on Cancer (IARC)
Neural Regeneration Research Organizations
Research Drug Monitoring Authorities
AI Solution Providers for Drug Discovery
Medical Devices manufacturers
Government Ministries and Departments of Healthcare
Period Captured in the Report
Historical Period: 2017-2021
Forecast Period: 2022-2028F
Frequently Asked Questions
What is the Study Period of this Market Report?
The Global Biophotonics Market is covered from 2017-2028 in this report, which includes a forecast for the period 2022-2028.
What is the Future Growth Rate of the Global Biophotonics Market?
The Global Biophotonics Market is expected to witness a CAGR of about 12% over the next 6 years.
What are the Key Factors Driving the Global Biophotonics Market?
Advances in optical technologies in the aerospace and telecommunications sectors, combined with the availability of private and government funds for R&D are expected to be the primary drivers of this market.
Which is the Largest Application Segment within the Global Biophotonics Market?
The analytical sensing segment holds the largest share of the Global Biophotonics Market.
Who are the Key Players in Global Biophotonics Market?
Affymetrix Inc., Andor Technology, BD (Becton, Dickinson and Company), Carl Zeiss AG, Olympus Corporation, Hamamatsu Photonics K.K, Zecotek Photonic Inc., Idex Corporation, IPG Photonics, Oxford Instruments Plc., among others are the major companies operating in Global Biophotonics Market.
Scope
2.7.1 By Technology
2.7.2 By End-User
2.7.3 By Application
2.7.4 By Region
3.2.1 In-Vivo
3.2.2 In-Vitro
3.2.3 Key Takeaways from Market Segmentation by Technology
4.2.1 Tests and Components
4.2.2 Medical Therapeutics
4.2.3 Medical Diagnostics
4.2.4 Non-Medical Application
4.2.5 Key Takeaways from Market Segmentation by End-User
5.2.1 Surface Imaging
5.2.2 Inside Imaging
5.2.3 See-through Imaging
5.2.4 Microscopy
5.2.5 Bio Sensors
5.2.6 Analytical Sensing
5.2.7 Spectromolecular
5.2.8 Others
5.2.9 Key Takeaways from Market Segmentation by Application
8.4.1 Major Production and Consumption Hubs in North America
8.4.2 Notable Emerging Biophotonics Companies in North America
8.4.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technology, 2017-2028
8.4.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by End-User, 2017-2028
8.4.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028
8.4.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028
USA
Canada
Mexico
8.5.1 Major Production and Consumption Hubs in Europe
8.5.2 Notable Emerging Biophotonics Companies in Europe
8.5.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technology, 2017-2028
8.5.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by End-User, 2017-2028
8.5.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028
8.5.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028
Germany
UK
France
Italy
Spain
8.6.1 Major Production and Consumption Hubs in the Asia Pacific
8.6.2 Notable Emerging Biophotonics Companies in the Asia Pacific
8.6.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technology, 2019-2028
8.6.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by End-User, 2019-2028
8.6.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2019-2028
8.6.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028
China
Japan
India
Australia
South Korea
8.7.1 Major Production and Consumption Hubs in The Middle East and Africa
8.7.2 Notable Emerging Biophotonics Companies in The Middle East and Africa
8.7.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technology, 2017-2028
8.7.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by End-User, 2017-2028
8.7.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Application, 2017-2028
8.7.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028
Saudi Arabia
South Africa
8.8.1 Major Production and Consumption Hubs in South America
8.8.2 Notable Emerging Biophotonics Companies in South America
8.8.3 Market Revenue Share, Historic Growth, Outlook and Forecasts by Technology, 2017-2028
8.8.4 Market Revenue Share, Historic Growth, Outlook, and Forecasts by End-User, 2017-2028
8.8.5 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Appliction, 2017-2028
8.8.6 Market Revenue Share, Historic Growth, Outlook, and Forecasts by Major Countries, 2017-2028
Brazil
Argentina
Disclaimer